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Abstract
Background The LACE index scoring tool (Length of stay, Acuity of admission, Co-morbidities and Emergency department 
visits) has been designed to predict hospital readmissions. We evaluated the ability of the LACE index to predict age-specific 
frequent admissions and mortality.
Methods Analysis of prospectively collected data of alive-discharge episodes between 01/04/2017 and 31/03/2019 in an 
NHS hospital. Data on 14,878 men and 17,392 women of mean age 64.0 years, SD = 20.5, range 18.0–106.7 years were 
analysed. The association of the LACE index with frequency of all-cause readmissions within 28 days of discharge and over 
a 2-year period, and with all-cause mortality within 30 days or within 6 months after discharge from hospital were evaluated.
Results Within LACE index scores of 0–4, 5–9 or ≥ 10, the proportions of readmission ≥ 2 times within 28 days of discharge 
were 0.1, 1.3 and 9.2% (χ2 = 3070, p < 0.001) and over a 2-year period were 1.7, 4.8 and 19.1% (χ2 = 3364, p < 0.001). 
Compared with a LACE index score of 0–4, a score ≥ 10 increased the risk (adjusted for age, sex and frequency of admis-
sions) of death within 6 months of discharge by 6.8-fold (5.1–9.0, p < 0.001) among all ages, and most strongly in youngest 
individuals (18.0–49.9 years): adjusted odds ratio = 16.1 (5.7–45.8, p < 0.001). For those aged 50–59.9, 60–69.9, 70–79.9 
and ≥ 80 years, odds ratios reduced progressively to 9.6, 7.7, 5.1 and 2.3, respectively. Similar patterns were observed for 
the association of LACE index with mortality within 30 days of hospital discharge.
Conclusions The LACE index predicts short-term and long-term frequent admissions and short-term and medium-term 
mortality, most pronounced among younger individuals, after hospital discharge.
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Introduction
Healthcare services are continually overstretched due to 
increasing demand, primarily from an expanding ageing 
population living with multiple chronic conditions and dis-
abilities [1–3]. Many such individuals have frequent early 
hospital readmissions [4] and prolonged length of stay in 
hospital [5, 6], imposing a high pressure on healthcare 
systems [7, 8]. Information on the number of individuals 
with high risk of readmission and mortality would allow 
healthcare teams to formulate effective clinical plans and 
resources. The LACE index scoring tool, based on Length 
of stay, Acuity of admission, Co-morbidities and Emer-
gency department visits, has been designed to predict early 
hospital readmissions and death [9] and has been imple-
mented widely across hospitals in the UK and in many 
other countries [10–14].
The LACE index represents a cluster of features that 
indicate the health status of an individual; the higher the 
index score, the poorer is their health and a greater risk of 
death. The role of the LACE index in relation to admis-
sions and mortality has been explored, but studies tend 
to focus primarily on older individuals and short periods 
after discharge from hospital (up to about one month) 
before readmission [14, 15], or death [10–14]. Among 
the overall population in England and Wales, the propor-
tions of younger adults aged 18–29, 30–39, 40–49 and 
50–59 years are 16.2, 13.3, 14.6 and 12.1%, while the 
respective proportions of older adults aged 60–69, 70–79 
and over 80 years are lower, are 10.8, 7.1 and 4.6% [16]. 
However, there is a paucity of data on the ability of the 
LACE index to predict age-specific mortality occurring 
after discharge and at times greater than one month after 
discharge, and frequent readmissions over a prolonged 
period [17]. In this study, we quantify the ability of the 
LACE index to predict, in adults aged between 18 and 
107 years, the risk of all-cause frequent unplanned read-
missions (within 28 days of discharge) and multiple read-
missions over a period of two years, and also to predict 
the risk of all-cause mortality within 30 days or within six 
months of discharge from hospital.
Methods
Study design, participants and setting
Data of consecutive alive-discharge episodes over two 
years between 1st April 2017 and 31st March 2019 in a 
single National Health Service hospital were prospectively 
collected. The data comprised clinical characteristics and 
care quality including age, sex, primary diagnosis on 
admission, the length of stay in hospital, nature of the 
admission, co-morbidities and number of previous emer-
gency department visits.
Measurement
Co-morbidities were coded according to ICD-10 for calcula-
tion of the Charlson co-morbidity index [18, 19]. Informa-
tion on the frequency of unplanned admissions and read-
missions within 28 days and over a two-year period, and 
mortality within 30 days and up to six months after hospital 
discharge was recorded. Cancer and obstetrics spells were 
excluded in line with the NHS data collection for general 
hospital admissions [20].
The LACE index was computed (https ://www.mdcal 
c.com/lace-index -readm issio n) from length of stay (score 
range 0–7), acuity of admission (score 0 or 3), co-morbidity 
(score range 0–5), emergency department visits (score range 
0 or 4) with the scale ranging from 0 to 19 and the likeli-
hood of outcome risk (mortality) is raised with increasing 
score [9].
Categorisation of variables
LACE indices were grouped into low (score = 0–4), mod-
erate (score = 5–9) and high (score ≥ 10) risk [15, 21, 22]. 
Age was categorised by decades from 50 years old: 50–59.9, 
60–69.9, 70–79.9 and ≥ 80 years. All those between 18 and 
49.9 years were grouped together due to low mortality 
rates, while those between 80 and 107 years were combined 
together due to small numbers – only 2461 (7.6%) patients 
were older than 90 years. Readmissions within 28 days of 
discharge or over a period of two financial years were cate-
gorised into three groups: No readmission, readmitted once, 
and readmitted ≥ 2 times.
Statistical analysis
Chi-square tests were used to assess the relationship between 
the proportions of all-cause readmissions and rates of all-cause 
mortality in relation to the LACE index. Receiver operating 
characteristic (ROC) curves were constructed to determine the 
area under the curve (AUC) for the LACE index as a predictor 
of outcomes (mortality or frequent admissions). Cox regres-
sion survival analysis and Kaplan–Meier survival curves were 
constructed to examine the risk of mortality after discharge. 
Logistic regression was conducted using categories of LACE 
index scores; 0–4 (reference group), 5–9 and ≥ 10 as the pre-
dictor variable of frequent readmissions (≥ 2 times within 
28 days of discharge or ≥ 2 times over a 2-year period), or mor-
tality within 30 days or within six months of hospital discharge 
(dependent variables). For analysis of frequent admissions, 
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data were adjusted for age and sex. For analysis of mortal-
ity, data were presented in three models; model 1: unadjusted, 
model 2: adjusted for age and sex, and model 3: adjusted for 
age, sex and frequency of admission in all ages first, followed 
by age-specific analysis. Odds ratios (OR) are given with 95% 
confidence intervals (CI). Analyses were performed using IBM 
SPSS Statistics, v23.0 (IBM Corp., Armonk, NY).
Results
Subject characteristics
Data for a total of 32,270 patients (14,878 men) and (17,392 
women) aged 18–106.7 yr (mean = 64.0 years, SD = 20.5) 
were analysed. There were 29.3% of patients with a LACE 
index score of ≥ 10. A total of 11.6% were readmitted within 
28 days (8.1% readmitted once and 3.3% readmitted ≥ 2 
times), and 21.6% were readmitted over a 2-year period 
(13.5% readmitted once and 8.1% readmitted ≥ 2 times). 
There were 834 (2.6%) and 2192 (6.8%) patients died within 
30 days (mean age of death 81.5 years, SD 12.0) and six 
months of discharge (mean age of death 81.2 years, SD 
12.1), respectively (Table 1).
The proportions for those who were readmitted ≥ 2 times 
within 28 days of discharge were 1.0% (18–49.9 years), 1.5% 
(50–59.9 years), 2.4% (60–69.9 years), 3.3% (70–79.9 years) 
and 6.7% (≥ 80 years) (χ2 = 1087, p < 0.001), and for those 
who were readmitted ≥ 2 times over a 2-yr period were 3.3% 
(18–49.9 years), 5.1% (50–59.9 years), 6.7% (60–69.9 years), 
8.7% (70–79.9 years) and 14.4% (≥ 80 years) (χ2 = 1335, 
p < 0.001).
The proportions of patients with a LACE index 
score ≥ 10 also rose steeply with age: 1.7% (18–49.9 years), 
5.6% (50–59.9  years), 18.0% (60–69.9  years), 39.1% 
(70–79.9 years) and 66.6% (80–89.9 years) (χ2 = 15,804, 
p < 0.001) and with frequency of readmission within 28 days 
of discharge: 24.5% (no readmission), 59.3% (one readmis-
sion) and 82.6% (≥ 2 readmissions) (χ2 = 3070, p < 0.001), 
and with frequency of readmission over the 2-year period of 
study: 22.2% (no readmission), 46.0% (one readmission) and 
69.1% (≥ 2 readmissions) (χ2 = 3364, p < 0.001).
ROC analysis to generate AUC values showed that the 
LACE index as a predictor of mortality within six months 
of hospital discharge was 80.5% (95%CI = 79.7–81.3) and 
frequent readmissions was 84.0%, (95%CI = 83.0–85.1).
LACE index as predictor of all‑cause unplanned 
readmissions
Within LACE index score groups of 0–4, 5–9 or ≥ 10, the 
proportions of readmission ≥ 2 times within 28 days of dis-
charge were 0.1, 1.3 and 9.2% (χ2 = 3070, p < 0.001) and 
over a 2-year period were 1.7, 4.8 and 19.1% (χ2 = 3364, 
p < 0.001) (Fig.  1). Compared with individuals with a 
LACE index score of 0–4 (reference group), those with a 
score of 5–9 had increased risk (adjusted for age and sex) 
of frequent admissions (≥ 2 times) within 28 days after 
discharge: OR = 10.4 (95% CI = 5.9–18.5, p < 0.001) and 
over a 2-yr period: OR = 3.1 (95% CI = 2.6–3.7, p < 0.001). 
This further increased in those with a score ≥ 10, frequent 
admissions within 28 days after discharge: OR = 94.2 (95% 
CI = 53.0–167.4, p < 0.001) and over a 2-yr period OR = 15.3 
(95% CI = 12.6–18.6, p < 0.001).
LACE index as predictor of all‑cause mortality
The proportions of patients who died within 30 days of 
discharge rose from 0.1% in the lowest LACE index group 
(0–4) to 1.4% in intermediate group (5–9) and up to 6.8% 
in the highest group (≥ 10) (χ2 = 957, p < 0.001). The cor-
responding figures for those who died within six months of 
discharge were 0.7, 3.9 and 17.0% (χ2 = 2275, p < 0.001). 
Compared with a LACE index score = 0–4, a score ≥ 10 
increased the risk (adjusted for age, sex and frequency of 
admissions) of death within three months by 13.5-fold 
(95%CI = 7.4–24.6, p < 0.001) or within six months of dis-
charge by 6.8-fold (5.1–9.0, p < 0.001).
Table 1  Subject characteristics of 14,878 men (mean 
age = 63.9  years, SD = 19.3, range 18.0–104.1) and 17,392 women 
(mean age = 64.1 years, SD = 21.6, range 18.0–106.7)







 ≥ 80 years 8756 27.1
LACE index categories
LACE < 4 9330 28.9
LACE 4–9 13,500 41.8
LACE ≥ 10 9440 29.3
Number of readmissions within 28 days of discharge
None 28,548 88.5
Once 2666 8.3
 ≥ 2 times 1056 3.3
Total number of readmissions over two years
None 25,295 78.4
Once 4360 13.5
 ≥ 2 times 2615 8.1
Mortality status
Death within 30 days of admission 834 2.6
Death within six months of admission 2192* 6.8
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Compared to those with a LACE index < 4 (mean 
for survival time from discharge = 32.1  months, 
95%CI = 32.0–32.2), those with a LACE index of 4–9 
or ≥ 10 had a significantly shorter survival with mean for 
survival time from discharge = 30.6 (95%CI = 30.5–30.8) 
and 29.5 (95%CI = 25.0–25.5) months respectively, log rank 
(Mantel-Cox) test: χ2 = 3382, p < 0.001. The hazard ratio, 
adjusted for age, sex and frequency of readmissions, was for 
a LACE index 4–9 = 2.58 (95% CI = 2.11–3.14, p < 0.001) 
and for a LACE index ≥ 10 = 6.38 (95% CI = 5.21–7.18, 
p < 0.001) (Fig. 2).
A LACE index predicted mortality most strongly in 
younger individuals (18–49.9  years): a score ≥ 10 was 
associated with greater risk of death within 30 days after 
discharge: OR = 30.5 (95%CI = 4.6–202.9, p < 0.001), 
and death within six months after discharge: OR = 16.1 
(5.7–45.8, p < 0.001). For those aged 50–59.9, 60–69.9, 
70–79.9 and ≥ 80 years, ORs reduced to 20.5, 7.5, 15.6 and 
5.3 for death within 30 days and to 9.6, 7.7, 5.1 and 2.3 for 
death within six months after hospital discharge, respec-
tively (Table 2).
Discussion
This study, over a period of 2 years, found a high LACE 
index was related to all-cause frequent readmissions within 
28 days, as well as over a two-year period, after hospital 
discharge. The same relation was observed for all-cause 
mortality within 30 days or six months post-hospital dis-
charge. The risk of mortality was most pronounced among 
younger individuals; patients aged 18–49.9 years with a 
LACE index score ≥ 10 had a 30.5-fold increased risk of 
death within 30 days and a 16.1-fold increased risk of death 
within 6 months of discharge.
Evidence from this study supports the use of a LACE 
index as a valuable tool for identifying individuals at risk. 
The proportions of patients with a high LACE index score 
(≥ 10) are relatively high, but have been reported to range 
between 16.0–48.5% [13, 21, 22], compared with 29.3% 
in this study. However we observed that these values vary 
with age; the proportion of individuals with LACE index 
scores ≥ 10 was only 1.7% among the youngest group 
(18–49.9 years) and more than doubled with each follow-
ing decade of age to a peak level of 69.1% among those 
aged ≥ 80 years. It is therefore important to take age into 
account when the rates of patients with high LACE index 
are analysed or reported.
Our findings of the overall rate (11.6%) of readmissions 
within 28 days of discharge was similar to that (12.6%) 
reported by Gruneir et al. [21] and by Lim et al. (11.6%) 
[23], but lower than the figure (18.4%) reported by Tan 
et al. [22], probably due to age differences between study 
populations. The observation of increased risk of frequent 
readmission among those with LACE index scores ≥ 10 was 
consistent with previous studies [21, 22]. In this study, we 
have also found that almost a fifth of patients with LACE 
index score ≥ 10 to be at risk of multiple readmissions (≥ 2 
times) in the long-term (two-year period). These findings 
provide valuable information to healthcare teams to identify 
those at long-term risk of readmissions to support preven-
tative and early interventional measures to those who are 
most vulnerable. This will improve patient care and reduce 
pressure and costs to healthcare services. Efforts have been 
made to reduce hospital readmissions such as the Hospital 
Readmissions Reduction Program (HRRP) in the US but 
results have been mixed due to increased mortality [24]. 
It is therefore important to address the balance of benefit 
and risk of readmissions reduction to avoid missing high 
Fig. 1  Proportions of patients readmitted within 28 days of discharge; 
group differences: χ2 = 3070, p < 0.001 (a) or readmitted over a two 
year period; group differences: χ2 = 3364, p < 0.001 (b)
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risk patients who remain reliant on hospital readmission for 
necessary treatment.
The mortality rates observed in our study were also 
comparable to those recently reported for 30 days [25] and 
6 months of discharge [26, 27]. There was a clear increas-
ing trend in the risk of mortality from higher LACE index 
scores in the youngest age group. This trend continued to 
persist with older age groups but was progressively less pro-
nounced. These increased risks were adjusted for age, sex 
and frequency of admissions. As far as we are aware, this 
is the first study to demonstrate an age-specific relationship 
between the LACE index and mortality and was achieved 
over a wide range of age (18–107 years). Lowering the cut-
off level of a LACE index score for younger individuals may 
be necessary to identify more patients at high risk of mortal-
ity after hospital discharge.
This study also demonstrated that the LACE index has 
predictive validity for short-term (30-days) and medium-
term (6-months) mortality, with clear stepwise increments in 
mortality. This suggests further research is required to gain 
greater insights into those younger individuals who have 
high LACE index scores, to lower their risk of death after 
discharge from hospital.
The strengths of this study lie in its large number of con-
secutive patients, which enable us to estimate the risk of 
mortality by decades of age, ranging from 18 to 107 years. 
Appropriate adjustments were made including age, sex and 
frequency of admission. Further adjustment for primary 
diagnosis on admission did not change these associations. 
Our hospital is typical of a General District Hospital in the 
UK. Our previous studies examining other health outcomes, 
using data from three other hospitals within the same county, 
showed very similar characteristics and indeed with the rest 
of the UK [28, 29]. Any bias is therefore likely to be minimal 
in our study. The present study did not collect information 
on socioeconomic status, employment or provenience (urban 
or rural) that could have some bearing on the outcomes. We 
employed the validated LACE index as a prognostic tool 
to predict outcome measures while cut-off points of 0–4, 
5–9 and ≥ 10 were based on previous studies [15, 21]. These 
cut-off points are arbitrary therefore raising the score above 
10 for the “high-risk” group would identify higher rates of 
mortality. Conversely lowering the cut-off score below 4 for 
the “low-risk” group would reduce rates of mortality, thus 
exaggerating the predictive ability (ORs) of mortality by the 
LACE index. Further studies to identify age-specific cut-offs 
for the LACE index as an indicator of adverse outcomes 
(such as mortality) are required.
In conclusion, the LACE index predicts short-term and 
long-term frequent admissions and short-term and medium-
term mortality, most pronounced among younger individu-
als, after hospital discharge. Raising awareness of younger 
individuals with a high LACE score is recommended.
Fig. 2  Kaplan–Meier survival 
plot in patients with a LACE 
index < 4 (dotted green line), 
4–9 (dashed blue line) and ≥ 10 
(solid red line). The vertical 
dotted black line shows the 
6-month time for one of the 
mortality estimates. The table 
beneath the figure shows the 
number of at-risk patients at 
various time points for the three 
LACE index cohorts
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